CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in KURA — Kura Oncology, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in KURA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,420,108
+$1,803,766 QoQ
Shares Held
676,400
-2.1% QoQ
Ownership
0.760%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. KURA ranks #117 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in KURA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,420,108 | 676,400 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,616,342 | 690,817 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,386,063 | 710,882 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,300,279 | 711,896 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,034,978 | 699,303 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,112,724 | 623,140 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $5,535,152 | 635,494 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $12,211,562 | 624,952 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $12,577,319 | 610,846 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,770,782 | 598,724 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,340,213 | 579,987 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,138,399 | 563,421 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,049,622 | 477,280 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,760,219 | 470,991 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,820,687 | 469,032 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,165,481 | 451,353 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,607,566 | 469,589 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,684,905 | 477,917 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,519,520 | 465,680 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,512,597 | 454,490 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $9,396,490 | 450,671 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,530,027 | 443,227 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $13,770,729 | 421,639 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,030,951 | 360,018 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,368,062 | 329,329 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $2,513,976 | 252,661 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||